AR029855A1 - Formas de sal de un inhibidor de la proteasa del hiv - Google Patents

Formas de sal de un inhibidor de la proteasa del hiv

Info

Publication number
AR029855A1
AR029855A1 ARP010103445A ARP010103445A AR029855A1 AR 029855 A1 AR029855 A1 AR 029855A1 AR P010103445 A ARP010103445 A AR P010103445A AR P010103445 A ARP010103445 A AR P010103445A AR 029855 A1 AR029855 A1 AR 029855A1
Authority
AR
Argentina
Prior art keywords
salt forms
protease inhibitor
hiv protease
inhibitors
useful
Prior art date
Application number
ARP010103445A
Other languages
English (en)
Original Assignee
Du Pont Pharm Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Pharm Co filed Critical Du Pont Pharm Co
Publication of AR029855A1 publication Critical patent/AR029855A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

La presente se relaciona en general con formas de sal del compuesto de formula (1), que son utiles como inhibidores de las proteasas del HIV, composiciones farmacéuticas que comprenden las mismas y métodos para usar las mismas para tratar infecciones virales.
ARP010103445A 2000-07-19 2001-07-20 Formas de sal de un inhibidor de la proteasa del hiv AR029855A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21979400P 2000-07-19 2000-07-19

Publications (1)

Publication Number Publication Date
AR029855A1 true AR029855A1 (es) 2003-07-16

Family

ID=22820809

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010103445A AR029855A1 (es) 2000-07-19 2001-07-20 Formas de sal de un inhibidor de la proteasa del hiv

Country Status (4)

Country Link
US (1) US20020022742A1 (es)
AR (1) AR029855A1 (es)
AU (1) AU2001280634A1 (es)
WO (1) WO2002010124A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6831164B2 (en) 2001-07-11 2004-12-14 Schering Aktiengesellschaft Process for the production of peracylated 1-0-glycosides
US8193227B2 (en) 2003-12-11 2012-06-05 Abbott Laboratories HIV protease inhibiting compounds
US20050131042A1 (en) * 2003-12-11 2005-06-16 Flentge Charles A. HIV protease inhibiting compounds
US20100082487A1 (en) * 2008-09-26 2010-04-01 Giftango Corporation Systems and methods for managing a virtual card based on geographical information

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150556A (en) * 1995-03-10 2000-11-21 G. D. Dearle & Co. Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
EP1140983A1 (en) * 1999-01-13 2001-10-10 Bristol-Myers Squibb Pharma Company Bis-amino acid sulfonamides containing n-terminally a fluoro-substituted benzyl group as hiv protease inhibitors

Also Published As

Publication number Publication date
WO2002010124A2 (en) 2002-02-07
WO2002010124A3 (en) 2003-05-01
US20020022742A1 (en) 2002-02-21
AU2001280634A1 (en) 2002-02-13

Similar Documents

Publication Publication Date Title
MX2022015812A (es) Inhibidores de cisteina proteasas y sus metodos de uso.
ES2177868T3 (es) Hidroxietilaminosulfonamidas de alfa- y beta-aminoacidos utiles como inhibidores de proteasas retroviricas.
ES2240446T3 (es) Inhibidores de serina proteasas, particularmente la proteasa ns3 del virus de la hepatitis c.
ES2169880T3 (es) Inhibidores de proteasas de serina, particularmente de la proteasa ns3 del virus de la hepatitis c.
PA8559101A1 (es) Inhibidores del factor xa y de las otras proteasas de serina implicadas en la cascada de la coagulacion
BRPI0411900B8 (pt) compostos e composições farmacêuticas compreendendo os mesmos
CY1112267T1 (el) Νεα πεπτιδια ως αναστολεις πρωτεασης ns3-σερινης του ιου ηπατιτιδας c
SE0201976D0 (sv) Novel compounds
DK1654261T3 (da) Hepatitis C-inhibitorforbindelser
DOP2009000094A (es) Inhibidores de la proteasa ns3 del hcv
BR0305258A (pt) Inibidores de polimerase de ns5b de hcv
EA200601007A1 (ru) 7-фенилалкилзамещённые 2-хинолиноны и 2-хиноксалиноны в качестве ингибиторов поли(адф-рибоза)полимеразы
CR9614A (es) Inhibidores heterobiciclicos de las metaloproteasas
ES2187640T3 (es) Inhibidores de proteasa retrovirales de aminoacido-hidroxietilamino-sulfonamida.
CL2004000076A1 (es) Compuestos derivados de indol, inhibidores de polimerasa, sales; composicion farmaceutica que los comprende; procedimiento de preparacion de dichos compuestos; compuestos intermediarios; y uso del compuesto para tratar una infeccion causada por el vi
BRPI0416902A (pt) inibidores de ns3/ns4a serina protease do vìrus da hepatite c
EA200400648A1 (ru) N, n'-замещенные производные 1,3-диамино-2-гидроксипропана
EA200800670A1 (ru) Ингибиторы сериновых протеаз
ES2157437T3 (es) Inhibidores de proteasas retrovirales de sulfonilalcanoilamino-hidroxietilamino-sulfonamida.
CY1107342T1 (el) Χρηση παραγωγων νιτριλιου ως φαρμακο
ES2190793T3 (es) Inhibidores de proteasas retrovirales de heterociclocarbonil aminoacido hidroxietilamino sulfonamida.
NO20033220L (no) Inhibitorer for cruzipain og andre cysteinproteaser
NO20005261L (no) Nye heterocyklisk substituerte amider med cystein-protease- inhiberende virkning
EA200701692A1 (ru) Ингибиторы протеазы вич
ATE382604T1 (de) Aminosäure-derivate als hiv aspartyl-protease- inhibitoren

Legal Events

Date Code Title Description
FB Suspension of granting procedure